Ignite Creation Date:
2024-05-05 @ 4:38 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00287547
Status:
COMPLETED
Last Update Posted:
2011-04-25
First Post:
2006-02-06
Brief Title:
Phase II Randomized Double-Blind Placebo-Controlled Study of BMS-188667 CTLA4Ig in Patients With Psoriasis Vulgaris
Sponsor:
Bristol-Myers Squibb
Organization:
Bristol-Myers Squibb
Key Dates - Follows AllAPIJSON File Order
Start Date:
1997-03
Start Date Type:
None
Primary Completion Date:
1998-01
Primary Completion Date Type:
ACTUAL
Completion Date:
1998-01
Completion Date Type:
ACTUAL
First Submit Date:
2006-02-06
First Submit QC Date:
February 6 2006
Study First Post Date:
2006-02-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2011-04-11
Disp First Submit QC Date:
April 11 2011
Disp First Post Date:
2011-04-25
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2011-04-11
Last Update Post Date:
2011-04-25
Last Update Post Date Type:
ESTIMATED